Canada Pharmacy Online Recommends Fewer Retests for Normal Bone Density

Osteoporosis is a debilitating disease but progresses very slowly in women with normal bone density after the age of 65 years. Canada Pharmacy Online suggests fewer bone density tests, and women could wait for even 15 years after initial assessment to have a retest. Researchers have found repeated tests do not actually help in any way, as the risk of developing osteoporosis is minimal after initial tests reveal normal bone density.

Retests Not Needed According To Recent Study

Researchers affiliated with Medical Epidemiology and Biostatistics based at University of California in San Francisco conducted further research based on an earlier study conducted by Centers for Disease Control and Prevention. It indicated approximately 70% women did not have osteoporosis. Findings led to questions being asked whether frequent testing was really required.

The present study tested 5,000 women over the age of 67 years. Findings of the research published in the New England Journal of Medicine clearly showed women with healthy bones at the age of 65 years could easily wait for another 15 years before opting for a retest, as osteoporosis develops extremely slowly in such cases. Canada Pharmacy Online feels precautionary measures are not at all required in terms of opting for regular bone density tests. In cases where bone loss is observed, people can buy Boniva to prevent loss and initiate growth when needed.

Studies have already shown less than 10% women experience fractures and broken bones at the age of 80 years, if they had normal bone density at the age of 65 years. Testing guidelines set by the US Preventive Services Task Force recommend bone density tests after every two years. The present study indicates frequent tests are therefore not required in older women, if they had healthy bones earlier. The belief that regular assessments help prevent osteoporosis is unwarranted and does not hold good.

Lack of Data Supported Frequent Testing

Around 12 million adults over the age of 50 years suffer from osteoporosis in the United States. Research also suggests nearly 50% postmenopausal women experience ill effects of osteoporosis at some stage or the other. Bone density tests were therefore recommended after every two years, because structured data to suggest specific tests for different age groups or medical conditions was lacking.

Tests are costly and paying around $250 for an assessment that is not necessary is an indulgence few people can afford. Chances of borderline cases and false positive results leading to unwarranted prescription drugs are quite high. In the United States, Medicare reimburses medical expenses related to bone density examinations in people older than 65 years.

Researchers based their findings on accumulated data related to necessity, marketing trends, and public belief on treatment plans and testing options. In the case of bone density examinations for osteoporosis, they found people either completely ignored signs of osteoporosis or took extra precautions by opting for frequent screenings.

Canada Pharmacy Online is convinced further research will help gather accurate information on treatment options for osteoporosis in younger men and women as well. More awareness needs to be created as has been done in the case of breast cancer. People must be encouraged with the right information to rule out osteoporosis.